{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:12:32Z","timestamp":1761293552372},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rce.2017.02.013","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T06:46:00Z","timestamp":1491029160000},"page":"398-404","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hiponatremia e insuficiencia cardiaca congestiva refractaria a tratamiento diur\u00e9tico. Utilidad del tolvapt\u00e1n"],"prefix":"10.1016","volume":"217","author":[{"given":"A.","family":"Pose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Gavira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Aramburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Com\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Manito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2017.02.013_bib0270","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.recesp.2013.03.014","article-title":"Epidemiolog\u00eda de la insuficiencia cardiaca en Espa\u00f1a en los \u00faltimos 20 a\u00f1os","volume":"66","author":"Sayago-Silva","year":"2013","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0275","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rce.2017.02.013_bib0280","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","article-title":"Mechanisms and models in heart failure. The biomechanical model and beyond","volume":"111","author":"Mann","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.rce.2017.02.013_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","article-title":"Developing therapies for heart failure with preserved ejection fraction: Current state and future directions","volume":"2","author":"Butler","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J."},{"key":"10.1016\/j.rce.2017.02.013_bib0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE registry","volume":"113","author":"Peacock","year":"2009","journal-title":"Cardiology."},{"key":"10.1016\/j.rce.2017.02.013_bib0300","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12968\/hmed.2014.75.Sup7.C103","article-title":"Diuretic resistance and its management","volume":"75","author":"Iqbal","year":"2014","journal-title":"Br J Hosp Med (Lond)."},{"key":"10.1016\/j.rce.2017.02.013_bib0305","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cardfail.2014.05.007","article-title":"Loop, diuretic resistance in heart failure: Resistance etiology-based strategies to restoring diuretic ef\ufb01cacy","volume":"20","author":"Cox","year":"2014","journal-title":"J Cardiac Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0310","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: Clinical characteristics and prognostic signi\ufb01cance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rce.2017.02.013_bib0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","article-title":"Decongestion in acute heart failure","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0325","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0330","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cardfail.2011.08.004","article-title":"Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure","volume":"17","author":"Davila","year":"2011","journal-title":"J Cardiac Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0335","first-page":"149","article-title":"High-Sensitivity Troponin T: A biomarker for diuretic response in decompensated heart failure patients","volume":"19","author":"Ferreira","year":"2014","journal-title":"Cardiol Res Pract."},{"key":"10.1016\/j.rce.2017.02.013_bib0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246","article-title":"Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure","volume":"6","author":"Kociol","year":"2013","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ejhf.35","article-title":"The kidney in congestive heart failure: \u2018Are natriuresis, sodium, and diuretics really the good, the bad and the ugly?\u2019","volume":"16","author":"Verbrugge","year":"2014","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0350","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/ph6070851","article-title":"Role of diuretics and ultrafiltration in congestive heart failure","volume":"6","author":"Shchekochikhin","year":"2013","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.rce.2017.02.013_bib0355","first-page":"2745","article-title":"Tailoring diuretic therapy in acute heart failure: Insight into early diuretic response predictors","volume":"10","author":"Ferreira","year":"2013","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0360","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9343(98)00365-9","article-title":"Diuretic treatment and diuretic resistance in heart failure","volume":"106","author":"Kramer","year":"1999","journal-title":"Am J Med."},{"issue":"Suppl. 2","key":"10.1016\/j.rce.2017.02.013_bib0365","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3949\/ccjm.73.Suppl_2.S20","article-title":"Vasopressin receptor antagonists: Mechanisms of action and potential effects in heart failure","volume":"73","author":"Goldsmith","year":"2006","journal-title":"Cleve Clin J Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1253\/circj.CJ-11-1441","article-title":"Hemodynamic classification of acute heart failure and their clinical application \u2014 an update","volume":"76","author":"Thomas","year":"2012","journal-title":"Circ J."},{"key":"10.1016\/j.rce.2017.02.013_bib0375","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0380","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol."},{"issue":"Suppl.","key":"10.1016\/j.rce.2017.02.013_bib0385","doi-asserted-by":"crossref","first-page":"2B","DOI":"10.1016\/j.amjcard.2005.03.002","article-title":"Hyponatremia in congestive heart failure","volume":"95","author":"Oren","year":"2005","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0390","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.158.10.1108","article-title":"NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics","volume":"158","author":"Heerdink","year":"1998","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0395","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"Ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0400","doi-asserted-by":"crossref","first-page":"165A","DOI":"10.1016\/0735-1097(93)90484-I","article-title":"Clinical trials of diuretic therapy in heart failure: Research directions and clinical considerations","volume":"22","author":"Cody","year":"1993","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0405","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0003-4975(96)01217-9","article-title":"Addition of a thiazide: An effective remedy for furosemide resistance after cardiac operations","volume":"63","author":"Vanky","year":"1997","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.rce.2017.02.013_bib0410","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","article-title":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","volume":"25","author":"Ferreira","year":"2014","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0420","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0425","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3747\/pdi.2012.00014","article-title":"Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: Review and perspective","volume":"33","author":"Nakayama","year":"2013","journal-title":"Perit Dial Int."},{"key":"10.1016\/j.rce.2017.02.013_bib0435","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10741-013-9416-5","article-title":"Renal dysfunction in acute congestive heart failure: A common problem for cardiologists and nephrologists","volume":"19","author":"Graciani","year":"2014","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.rce.2017.02.013_bib0440","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2017.02.013_bib0445","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.rce.2017.02.013_bib0450","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1527-5299.2005.04180.x","article-title":"Hyponatremia and heart failure \u2014 pathophysiology and implications","volume":"11","author":"Sica","year":"2005","journal-title":"Congest Heart Fail."},{"key":"10.1016\/j.rce.2017.02.013_bib0455","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.rce.2017.02.013_bib0460","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.rce.2017.02.013_bib0465","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J Cardiac Fail."},{"issue":"Suppl. 1","key":"10.1016\/j.rce.2017.02.013_bib0470","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s10557-011-6303-y","article-title":"Effects of tolvaptan on volume overload in Japanese patients with heart failure: Results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.rce.2017.02.013_bib0475","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.recesp.2012.09.012","article-title":"Uso del tolvapt\u00e1n en pacientes con hiponatremia debida a insuficiencia card\u00edaca: experiencia inicial","volume":"66","author":"Rodr\u00edguez-de Mu\u00f1oz","year":"2013","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0480","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.recesp.2012.12.015","article-title":"Eficacia del tolvapt\u00e1n en pacientes hospitalizados por insuficiencia card\u00edaca con hiponatremia refractaria. Experiencia cl\u00ednica en la pr\u00e1ctica diaria","volume":"66","author":"Salterain-Gonzalez","year":"2013","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0485","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jjcc.2012.08.020","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population","volume":"61","author":"Matsue","year":"2013","journal-title":"J Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0490","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1253\/circj.CJ-13-1255","article-title":"Immediate administration of tolvaptan prevents the exacerbation of acute kidney injury and improves the mid-term prognosis of patients with severely decompensated acute heart failure","volume":"8","author":"Shirakabe","year":"2014","journal-title":"Circ J."},{"key":"10.1016\/j.rce.2017.02.013_bib0495","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.12124","article-title":"Benefit of tolvaptan in the management of hyponatremia in patients with diuretic refractory congestive heart failure. The SEMI-SEC Project","author":"Pose","year":"2017","journal-title":"ESC Heart Failure."},{"key":"10.1016\/j.rce.2017.02.013_bib0500","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-013-6491-8","article-title":"Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: Design and rationale of the AQUAMARINE study","volume":"28","author":"Matsue","year":"2014","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.rce.2017.02.013_bib0510","unstructured":"Treatment of hyponatremia: Medical utility of vasopressin V2 receptor antagonism. Briefing document. Advisory Committee Meeting of the Cardiovascular and Renal Drugs Division of the US Food and Drug Administration. 25 June 2008 [consultado 6 Feb 2017]. Disponible en: http:\/\/www.fda.gov\/ohrms\/DOCKETS\/ac\/08\/briefing\/2008-4373b1-05.pdf"},{"key":"10.1016\/j.rce.2017.02.013_bib0515","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9629(15)40736-0","article-title":"The urine\/plasma electrolyte ratio: A predictive guide to water restriction","volume":"319","author":"Furst","year":"2000","journal-title":"Am J Med Sci."},{"key":"10.1016\/j.rce.2017.02.013_bib0520","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2014.03.020","article-title":"Hypertonic saline with furosemide for the treatment of acute congestive heart failure: A systematic review and meta-analysis","volume":"173","author":"Gandhi","year":"2014","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rce.2017.02.013_bib0525","first-page":"439","article-title":"Tratamiento de la hiponatremia inducida por el s\u00edndrome de secreci\u00f3n inadecuada de hormona antidiur\u00e9tica: algoritmo espa\u00f1ol multidisciplinar","volume":"34","author":"Runkle","year":"2014","journal-title":"Nefrologia."},{"key":"10.1016\/j.rce.2017.02.013_bib0530","unstructured":"Ficha t\u00e9cnica de tolvapt\u00e1n [consultado 10 Feb 2017]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000980\/WC500048716.pdf"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256517300760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256517300760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T02:25:55Z","timestamp":1535941555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256517300760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0014256517300760"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2017.02.013","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiponatremia e insuficiencia cardiaca congestiva refractaria a tratamiento diur\u00e9tico. Utilidad del tolvapt\u00e1n","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2017.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}